PSP Netherlands — PSP Vereniging Nederland

PSP Netherlands (PSP Vereniging Nederland)

Overview

PSP Vereniging Nederland (PSP Association Netherlands), commonly referred to as PSP Netherlands, is the national patient advocacy organization for progressive supranuclear palsy in the Netherlands. The organization provides support to Dutch patients and families, promotes research into PSP, and works to improve awareness and care of the condition within the Netherlands.

Research Excellence in the Netherlands

The Netherlands has a strong tradition of movement disorder research and neurology:

PSP Netherlands (PSP Vereniging Nederland)

Overview

PSP Vereniging Nederland (PSP Association Netherlands), commonly referred to as PSP Netherlands, is the national patient advocacy organization for progressive supranuclear palsy in the Netherlands. The organization provides support to Dutch patients and families, promotes research into PSP, and works to improve awareness and care of the condition within the Netherlands.

Research Excellence in the Netherlands

The Netherlands has a strong tradition of movement disorder research and neurology:

• Radboud University Medical Center, Nijmegen — World-renowned movement disorder research and PSP expertise
• Erasmus MC, Rotterdam — Neurodegeneration research and clinical care
• VU University Medical Center, Amsterdam — Dementia and tauopathy research
• Leiden University Medical Center — Neuroscience and neurodegenerative disease research

Mission and Activities

Patient Support

PSP Netherlands provides comprehensive support:

• National support network: Connecting patients across Dutch provinces
• Information resources: Dutch-language materials about PSP management
• Regional meetings: Patient and caregiver gatherings
• Caregiver support: Resources and networks for families

Research Funding

The organization supports Dutch PSP research:

• Research grants: Funding for Dutch scientists studying PSP
• International collaboration: Facilitating partnerships with European and global research groups
• Clinical trial promotion: Supporting Dutch participation in international trials
• Young investigator awards: Supporting training of Dutch researchers

European Integration

The Netherlands serves as a hub for European PSP research:

• European collaboration: Active participation in EU-funded research consortia
• Cross-border care: Coordination with neighboring countries (Belgium, Germany)
• [PSP Europe](/organizations/psp-europe): Participation in EU-wide advocacy efforts
• Research networks: Integration with European rare disease research initiatives

Healthcare System Context

The Dutch healthcare system provides excellent support for PSP patients:

• Movement disorder expertise: Specialized clinics at major university medical centers
• Integrated care: Coordination between neurology, rehabilitation, and primary care
• Long-term care: Home care and institutional care pathways for progressive conditions

Reference to CurePSP

PSP Netherlands operates as part of the international [CurePSP](/organizations/curepsp) network, providing access to global resources and research opportunities while maintaining independent national operations.

Leadership and Governance

PSP Netherlands is led by a board combining patient advocates and medical professionals:

• Chairman: Dr. Bart van de Warrenburg (neurologist, Radboud UMC)
• Board members: Include patients, caregivers, and researchers from across the Netherlands

Organizational Structure

The organization operates through:

• National coordination: Utrecht-based office
• Regional coordinators: Volunteer patient representatives in each province
• Online community: Digital platforms connecting Dutch patients and families

Clinical Research in the Netherlands

The Netherlands has become a European hub for PSP clinical research:

Key Research Centers

• Radboud University Medical Center, Nijmegen — Dr. Bart van de Warrenburg leads the Dutch PSP expertise center, one of Europe's largest PSP cohorts (400+ patients)
• Erasmus MC, Rotterdam — Neurodegeneration research, neuroimaging, and clinical trials
• VU University Medical Center, Amsterdam — Dr. Ania G. Sikorska research group, biomarker studies
• Leiden University Medical Center — Clinical phenotyping and outcome measure development
• University Medical Center Utrecht — Clinical trial design and patient-centered outcomes

Dutch Clinical Trials

| Trial | Phase | Dutch Sites | Focus |
|-------|-------|------------|-------|
| PROXIMA-PSP | Observational | Nijmegen, Rotterdam | Natural history, biomarkers |
| Tau therapeutics | Phase 2 | Nijmegen, Amsterdam | Disease modification |
| Symptom management | Phase 3 | Multiple | Quality of life interventions |

Scientific Contributions

Landmark Dutch Research

| Contribution | Journal | Year | Impact |
|-------------|---------|------|--------|
| PSP-QuiPE development | Movement Disorders | 2018 | Validated patient-reported outcome measure |
| Eye movement biomarkers | Neurology | 2019 | Quantified vertical saccade velocity as diagnostic tool |
| PROXIMA registry design | Orphanet J Rare Dis | 2020 | European registry framework for PSP |
| Genetic risk factors | Brain | 2021 | Identified novel risk variants in Dutch cohort |

Key Dutch Researchers

• Bart van de Warrenburg (Radboud UMC) — Clinical trials, disease phenotyping, outcome measures
• Jorien van der Heijden (Erasmus MC) — Neuroimaging biomarkers, MRI analysis
• John van den Bossche (VU Amsterdam) — Patient-centered outcomes, quality of life research

Healthcare System Context

The Netherlands' universal health insurance system (Zorgverzekeringswet) provides comprehensive PSP coverage:

Dutch Healthcare for PSP

• Movement disorder expertise: 6 specialized centers designated for atypical parkinsonism
• Integrated care: Coordination between neurology, rehabilitation, nursing, and social work
• Long-term care funding: Chronic care act (Wlz — Wet langdurige zorg) covers institutional and home care
• Palliative care: Embedded palliative care pathways for advanced PSP

Dutch Support Systems

• Buurtzorg model: Community nursing support for PSP patients at home
• Carer support: Kwaliteit van Leven indicator tracking, caregiver burden assessment
• Respite care: Dagbehandeling (day treatment) and kortverblijf (respite) services

Patient Support Services

Programs and Services

PSP Netherlands provides:

• National support hotline: Telephone and video support in Dutch
• Regional meetings: Monthly gatherings in Amsterdam, Rotterdam, Nijmegen, Maastricht, Groningen
• Caregiver education: Workshops on swallowing, communication, and falls management
• Equipment loans: Communication devices, positioning equipment, mobility aids

Dutch Patient Resources

• PSP Informatie: Dutch-language guides on PSP management and care
• Family days: Annual events bringing together Dutch PSP families
• Newsletter: Monthly updates on research, trials, and support services

Advocacy and Policy

Dutch Rare Disease Framework

The Netherlands has an advanced rare disease policy framework:

• NGDN (Nederlands Genoom Dagboek Netwerk): Dutch participation in rare disease registries
• Zorginstituut Nederland: Evaluates new therapies for reimbursement, important for PSP drugs
• Ministerie van VWS: Health ministry actively monitors PSP burden and care quality

European Engagement

• EURORDIS: Active participation in European rare disease advocacy
• ERN-RND: Dutch centers part of European reference network for rare neurological diseases
• CurePSP Europe: Active collaboration and funding initiatives

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PSP Netherlands — PSP Vereniging Nederland discovered through SciDEX knowledge graph analysis: